The Checklist for Early Recognition and Treatment of Acute Illness (CERTAIN)

N/ACompletedNCT01973829

Mayo Clinic5,215 enrolled

Overview

The purpose of the study is to test whether the health care provider access and training in CERTAIN (Checklist for Early Recognition and Treatment of Acute Illness), would facilitate timely and error free best-practice delivery and minimize preventable death and costly complications in critically ill patients.

Study Type

INTERVENTIONAL

Allocation

Purpose

SUPPORTIVE_CARE

Masking

NONE

Enrollment

5,215

Conditions

Critical Illness Sepsis Respiratory Failure Shock Coma Bleeding Trauma

Interventions

Checklist for Early Recognition and Treatment of Acute Illness (CERTAIN)OTHER

This study is about training and implementation of best critical care practices in the international ICUs with variable resources facilitated by access to a specifically designed electronic checklist

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion: All adult (≥ 18 years) patients admitted for the first time to the participating ICUs will be included. Exclusion: Not critically Ill, admitted for low risk monitoring, planned ICU admissions for routine postoperative surveillance for less than 24 hours after uncomplicated surgery, readmission and transferred from outside ICU.

Locations (30)

Outcomes

Primary Outcomes

Adherence to best critical care practices

Adherence to best practice in initial evaluation and treatment of critically ill medical and surgical patients Appropriate shock resuscitation Appropriate sepsis treatment Appropriate mechanical ventilation Appropriate peptic ulcer, deep vein thrombosis and infectious disease prophylaxis

Time frame: Participants will be followed for the duration of ICU stay, an expected average of 2 weeks

ICU and hospital lengths of stay

Patient will be followed till they get discharged from hospital for whatever length they stay.

Time frame: Participants will be followed for the duration of hospital stay, an expected average of 8 weeks

Secondary Outcomes

Mortality for 4 weeks

Patient will be followed for 4 weeks and hospital discharge(up to total 10 weeks post discharge)

Time frame: Participants will be followed for the duration of 4 weeks and hospital discharge (up to 10 weeks post discharge)

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.